Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Vanessa Veronica has a total of 18 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Aligning Mercury Governance With Livelihoods, Legal Frameworks, and Religious Norms

    by Amanda Adelina Harun, Vanessa Veronica, Fenty U. Puluhulawa

    This study aims to examine the health impacts of mercury exposure on miners and communities, analyse patterns of regulatory compliance in the context of largely informal mining, and evaluate the effectiveness of policies and legal instruments designed to reduce mercury use and mitigate environmental impacts. This study synthesises toxicological and biomonitoring evidence, community-based qualitative studies on practices and risk perceptions, and regulatory analysis in relation to international obligations. Results show that mercury biomarkers remain persistently high and there are neurological impacts on exposed populations, while informality limits oversight and weakens compliance. Interventions focused on enforcement often trigger displacement of activities (mining), rather than changes to more sustainable extraction practices. Policy effectiveness increases when regulations are combined with livelihood-sensitive supporting factors, including cooperative-based formalisation, access to financing and training, and technological transition through integrated governance. The study proposes a governance-livelihood-Islamic norm model and a compliance architecture aligned with maqasid al-sharia.


  • Open Access

    Transeksi Medula Spinalis Nontraumatik Inkomplit pada Kompresi Medula Spinalis Suspek Metastasis

    by Vanessa Veronica, Dony Ardianto

    Pendahuluan: Vertebra merupakan tulang tersering yang menjadi tempat metastasis, dan kompresi medulla spinalis dapat menjadi manifestasi awal keganasan. Insidensi kompresi medulla spinalis cenderung meningkat seiring dengan meningkatnya angka ketahanan hidup pasien kanker. Kami melaporkan kasus paraparesis spastik pada kompresi medulla spinalis suspek metastasis. Kasus: Seorang laki-laki berusia 62 tahun datang ke instalasi gawat darurat dengan keluhan kelemahan pada kedua anggota gerak bawah dan nyeri punggung bawah, bermula 1 bulan sebelum masuk rumah sakit dan semakin lama semakin memberat. Pasien tampak sakit sedang dan sadar penuh dengan temperatur tubuh 36,4oC, nadi 89 kali per menit, laju respirasi 18 kali per menit, saturasi oksigen 99%, tekanan darah 144/81 mmHg, dan skala nyeri 7. Pemeriksaan neurologi menunjukkan paraparesis spastik dengan kekuatan otot 1 pada kedua ekstremitas inferior disertai hilangnya sensasi sikap dan getar. Dijumpai gambaran massa di korpus vertebra thorakal 4 hingga 10 dengan massa paravertebral dan destruksi tulang di sekitarnya, disertai invasi ke intrakranial dan ekstrakranial medularis dengan lesi litik di vertebra lumbal 2, dan konsolidasi di segmen apikoposterior pulmo sinistra mengarah pada gambaran massa pulmo pada pemeriksaan computed tomography (CT) myelografi thorakolumbal. Ketorolac, metilprednisolon, dan sitikolin diberikan sebagai terapi. Pasien menunjukkan perbaikan nyeri dalam beberapa hari. Kesimpulan: Kompresi medulla spinalis akibat metastasis merupakan kegawatan onkologi dan paraparesis spastik serta defisit propriosepsi termasuk dalam dampak neurologisnya.

  • Open Access

    Medical Comorbidities as Predictors of COVID-19 Short-Term Mortality: A Historical Cohort Study

    by Rizaldy Pinzon, Vanessa Veronica

    Background: While the coronavirus disease 2019 (COVID-19) is most commonly associated with the respiratory system, disorders in other organ systems, such as the cardiovascular, neurologic, or renal, can also contribute to disease fatality. This study aimed to evaluate the relation of comorbidities to COVID-19 short-term mortality. Method: This was a single-center observational study with a historical cohort method at Bethesda Hospital Yogyakarta, Indonesia. COVID-19 diagnosis was made by utilizing reverse transcriptase-polymerase chain reaction (RT-PCR) on nasopharyngeal swabs. Patient data were retrieved from electronic medical records and used for Charlson Comorbidity Index assessments. In-hospital mortality was monitored throughout their hospital stay. Results: This study enrolled 333 patients. According to the total number of comorbidities in Charlson, 11.7% (n=39) of patients had no comorbidities; 30.9% (n=103) of patients had one comorbidity; 20.1% (n=67) of patients had two comorbidities; and 37.2% (n=124) of patients had more than three comorbidities. In multivariate analysis, these variables were significantly related to short-term mortality in COVID-19 patients: older age (odds ratio [OR] per year 1.64; 95% confidence interval [CI] 1.23-2.19; p 0.001), myocardial infarction (OR 3.57 ; 95% CI 1.49-8.56; p: 0.004), diabetes mellitus (OR 2.41; 95 CI 1.17-4.97; p: 0.017), renal disease (OR 5.18 ; 95% CI 2.07-12.97; p <0.001), and longer duration of stay (OR 1.20; 95% CI 1.08-1.32; p <0.001). Conclusion: Our study revealed multiple risk factors for mortality in patients with COVID-19. The coexistence of cardiovascular disease, diabetes, and renal problem are significant predictors of short-term mortality in COVID-19 patients.

  • Open Access

    Hydrocephalus Caused by Tuberculous Meningitis in an Immunocompetent Young Adult: A Case Report

    by Rizaldy Taslim Pinzon, Vanessa Veronica

    Background: Despite improved medical management, meningeal tuberculosis mortality and other outcomes have changed slightly over time due to a delay in diagnosis and treatment. This study reports a rare case of tuberculous meningitis in an immunocompetent host, calling into question the commonly held belief that tuberculous meningitis is a disease of immunocompromised individuals. Case Presentation: A 26-year-old male with no significant past medical history, tuberculosis, or indications of immunological compromise, was admitted to our hospital with a fever and altered mental status. He was drowsy, febrile (temperature of 38°C), had a heart rate of 110 beats per minute, and showed mild neck stiffness but no meningeal sign. A lumbar puncture on the third day of admission suggested tuberculous meningitis. He was treated for tuberculosis meningitis, and his condition slightly improved. However, the patient’s condition suddenly worsened, and a repeat contrast computed tomography (CT) of the brain showed the development of ventriculomegaly and basilar enhancement. Insertion of an emergency ventriculoperitoneal shunt was performed; however, the patient died ten days after hospital admission. Conclusion: We report a fatal case of tuberculous meningitis in an immunocompetent patient. Healthcare practitioners must be trained to identify and diagnose tuberculous meningitis promptly. Early treatment of tuberculous meningitis based on clinical diagnosis and symptoms improves clinical outcomes.


  • Open Access

    Acute dizziness and mental alteration associated with Moderna COVID-19 vaccine: a case report

    by Rizaldy Taslim Pinzon, Fillia Kristyawati Haryono, Nikolaus Erik Darmawan, Mia Amelia Mutiara Salikim, Vanessa Veronica

    Background: Due to a rising number of COVID-19 cases, the Indonesian government implemented public health programs to lower the rate. Since January 2021, one of the government’s primary policies has been the COVID-19 immunization program. Recently, the Moderna messenger ribonucleic acid (mRNA) vaccine is one of the COVID-19 vaccines used in Indonesia. Based on some research, Moderna has possible side effects throughout the body, including neurological symptoms. Case presentation: We describe a 39-year-old female with uncontrolled hypertension who showed behavioral change, communication difficulty, social withdrawal, and a confused state within 7 days from getting her first dose of the Moderna vaccine. The patient had a history of febrile convulsion in childhood. An increase of neutrophil-to-lymphocyte ratio (16.9) and C-reactive protein level (31.75 mg/L) indicates ongoing inflammation. Head CT scan shows no abnormalities. She received ceftriaxone, citicoline, and methylprednisolone. The patient was discharged on the seventh day and completely recovered 1 week later. This study is the first case report of encephalopathy following the administration of the Moderna COVID-19 vaccine reported in Indonesia up to our knowledge. Conclusion: Encephalopathy related to the Moderna COVID-19 vaccine should be acknowledged as an adverse effect of the Moderna COVID-19 vaccine.


  • Open Access

    Tetraparese spastik akibat schwannoma servikal: sebuah laporan kasus

    by Rizaldy Taslim Pinzon, Gusti Agung Sinta Shakuntala, Vanessa Veronica

    Introduction: Schwannoma is a benign nerve sheath tumor that occurs more frequently in the peripheral nervous system than in the central nervous system. Spinal schwannomas are most frequently found in the thoracic or lumbar regions but are uncommon in the cervical region. This paper describes a cervical schwannoma that is associated with spastic tetraparesis. Case Presentation: A 50-year-old man presented with the primary complaint of having difficulty moving his upper and lower limbs. The patient is fully conscious and has a temperature of 36.2°C, a respiratory rate of 22 breaths per minute, and a pulse rate of 108 beats per minute. Neurological evaluation revealed bilaterally diminished strength in the superior and inferior extremities. Cervical magnetic resonance imaging (MRI) with and without contrast revealed a grade 2 hernia nucleus pulposus (HNP) and an extramedullary-intradural mass in the anterior cervical vertebral canal region between C5 and C7, compressing and obliterating the cerebrospinal fluid spaces. A laminectomy was performed, and an intradural tumor mass in the C5-C7 region was obtained. Conclusion: Schwannomas, although rare, can cause spastic tetraparesis if they compress the cervical spinal cord. Latar Belakang: Schwannoma adalah tumor selubung saraf jinak yang lebih sering terjadi di luar sistem saraf pusat. Schwannoma spinal dapat terjadi di regio thorakal atau lumbar, namun jarang terjadi pada regio servikal. Studi ini melaporkan schwannoma servikal yang menyebabkan tetraparese spastik. Presentasi Kasus: Seorang laki-laki umur 50 tahun datang dengan keluhan utama kedua anggota gerak atas dan bawah sulit digerakkan. Pasien sadar penuh dengan suhu 36,2°C, laju respirasi 22 kali per menit, nadi 108 kali per menit. Pemeriksaan neurologis menunjukkan adanya penurunan kekuatan ekstremitas superior dan ekstremitas inferior bilateral. Magnetic resonance imaging (MRI) servikal dengan kontras dan tanpa kontras menunjukkan hernia nucleus pulposus (HNP) grade 2 dan massa ekstramedular-intradural pada regio kanalis vertebra servical anterior setinggi C5-C7 yang menyebabkan kompresi dan obliterasi ruang cairan serebrospinal. Dilakukan laminektomi dan didapatkan massa tumor intradural C5-C7. Kesimpulan: Schwannoma, walaupun jarang, dapat menyebabkan tetraparese spastik jika menekan medula spinalis servikal.

  • Open Access

    Ischemic Stroke Following Calloselasma rhodostoma Snakebite: A Rare Case Report

    by Rizaldy Taslim Pinzon, Radian Adhiputra Antonius, Vanessa Veronica

    Background: Ischemic stroke following a snakebite is a rare case. Snake venom consists of multiple components which can cause various symptoms and consequences. We report a case of ischemic stroke following Calloselasma rhodostoma snakebite, and this study was the first to report a case of ischemic stroke after snakebite in Indonesia. Case Presentation: A 72-year-old Mongoloid male presented with a history of snakebite one day before hospital admission with a swollen right lower leg with no history of hypertension, diabetes mellitus, or heart disease. The patient was conscious. His temperature was 36.5°C, pulse rate was 90 beats per minute, respiration rate was 30 breaths per minute, and blood pressure was 162/109 mmHg. The neurological examination showed left-side weakness and headache, with blood laboratory results showing prolonged prothrombin time (PT) and activated partial thromboplastin time (aPTT), leucocytosis, thrombocytopenia, and low haemoglobin. A computerized tomogram (CT) scan of the brain was taken, which revealed a sign of infarct in the pericallosal of the right lateral periventricular anterior horn. Conclusion: Although ischemic stroke following a snakebite is uncommon, it must be considered and monitored.


  • Open Access

    The Benefits of Add-on Therapy of Vitamin D 5000 IU to the Vitamin D Levels and Symptoms in Diabetic Neuropathy Patients: A Randomized Clinical Trial

    by Rizaldy Taslim Pinzon, Vincent Ongko Wijaya, Vanessa Veronica

    Background: Previous studies have demonstrated a significant relationship between vitamin D deficiency and the development of diabetic peripheral neuropathy (DPN). However, current studies are limited regarding the potential therapeutic benefits of vitamin D therapy in these patients. Objective: This study aimed to assess the effect of oral vitamin D supplementation in patients with diabetic peripheral neuropathy in addition to standard treatment. Methods: This study was a controlled, open-label, randomized clinical trial with an active comparator randomly allocated with a 1:1 ratio. The experimental group received an add-on oral vitamin D 5000 IU once daily and standard treatment (pregabalin, gabapentin, or amitriptyline) over eight weeks. The control group received standard treatment alone. The measured outcomes were the change in the score of the visual analog scale (VAS), numerical rating scale (NRS), and brief pain inventory (BPI). Vitamin D levels were also measured before and after the trial. Results: Data from 68 subjects with DPN was collected and analyzed. Most of them (60.3%) were female, aged 64.96 ± 8.3 years. After eight weeks of treatment, the experimental group showed a more significant reduction of mean VAS (− 3.34 ± 2.03 vs − 2.37 ± 2.2, p=0.044) and burning pain (1.76 ± 7.16 vs 6.18 ± 13.93, p=0.046) scores compared to controls. Mood also improves better in the experimental group (88.2% vs 70.6%, p=0.031). At the end of the study, vitamin D levels were also improved more significantly in the experimental group (40.02 ± 15.33 ng/mL vs 18.73 ± 6.88 ng/mL; p< 0.001) with greater changes from the baseline to week 8 (+24.14± 13.68 ng/mL vs +3.10± 4.20 ng/mL; p< 0.001) compared to control group. The intervention group showed a negative correlation between vitamin D level and VAS score (r = − 0.403, P = 0.018). There were no adverse events recorded in this study. Conclusion: The addition of oral vitamin D 5000 IU to standard treatment significantly improves pain, mood, and vitamin D levels more effectively than standard treatment alone in patients with diabetic neuropathy. Trial Registration: ClinicalTrials.gov.no NCT04689958.


  • Open Access

    Effect of DLBS1033 on Functional Outcomes for Patients with Acute Ischemic Stroke: A Randomized Controlled Trial

    by Rizaldy Taslim Pinzon, Raymond R. Tjandrawinata, Vincent Ongko Wijaya, Vanessa Veronica

    Background. There are still some unmet needs for stroke management and safety. DLBS1033 is a protein fraction extracted from the earthworm Lumbricus rubellus that has shown fibrinolytic and fibrinogenolytic activities, reduces blood viscosity, and inhibits platelet aggregation that it can be considered an add-on therapy and potential medical breakthrough in acute ischemic stroke management. Objective. This study is aimed at measuring the benefit of DLBS1033 in acute ischemic stroke management. Methods. This was a randomized, open-label trial at a referral stroke center from November 2019 to December 2020. Subjects who met the inclusion criteria were randomly divided into a control group and an experimental group. The control group received standard therapy consisting of aspirin 100 mg once daily, atorvastatin 20 mg once daily, and vitamin B12 100 mg three times daily. The experimental group received standard therapy and DLBS1033 three times daily. The functional outcomes were measured using the National Institutes of Health Stroke Scale (NIHSS), Barthel Index (BI), and modified Rankin Scale (mRS) at baseline, hospital discharge, and day 30. Results. Collected data from 180 subjects was analyzed. The NIHSS scores’ improvements were significantly greater in the experimental group compared to the control group at both hospital discharge ( vs. ; ) and day 30 ( vs. ; ). Compared with the control group, the improvements in the BI scores were significantly better in the experimental group, at both hospital discharge ( vs. ; ) and day 30 ( vs. ; ). The distribution of mRS scores was improved in both groups during 30 days of follow-up and was more favorable in the experimental group. In both groups, a favorable outcome (<path id="g190-83" d="M631 18C609 24 585 35 559 65C534 91 514 117 478 169C448 214 406 281 389 313C462 346 516 399 516 485C516 545 490 590 449 616C412 641 363 650 290 650H42V622C120 615 128 612 128 527V125C128 40 120 34 38 28V0H300V28C221 34 212...